Martínez-Bosch and colleagues proved that PARP-1 upregulates MDM2, VEGFR1, and MMP28, accelerating tumor proliferation and angiogenesis in pancreatic cancer [42]. Here, FLT1 is linked to pancreatic neoplasm.